VanEck Pharmaceutical ETF (PPH US) stock market data APIs
103.4975
-0.07(-0.1%)
as of December 29, 2025
Try our APIs with
free plan!
VanEck Pharmaceutical ETF Financial Data Overview
Price chart is built with
Anychart
Prev. Close
103.4975
Open
103.4272
High
103.6317
Low
103.1678
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get VanEck Pharmaceutical ETF data using free add-ons & libraries
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
VanEck Pharmaceutical ETF News
New
The Obesity Pill Rush: Healthcare ETFs to Gain as FDA Nods to Novo Drug
The recent U.S. Food and Drug Administration (FDA) approval of Novo Nordisk’s NVO oral obesity pill, Wegovy, marks a significant turning point in the fiercely competitive weight-loss drug market. Th...
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
The Invesco Pharmaceuticals ETF (PJP) was launched on June 23, 2005, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity m...
Pharma ETFs to Gain From Landmark UK-US Zero-Tariff Deal
At the onset of this month, the UK and U.S. governments signed a landmark pharmaceuticals trade deal aimed at rebalancing transatlantic commerce and securing access to innovative medicines. The core o...
Looking at the Narrative for Pepkor Holdings After Analyst Upgrades and Renewed Optimism
Pepkor Holdings has recently experienced a shift in analyst expectations, with the consensus price target decreasing from ZAR 32.76 to ZAR 31.74. This adjustment reflects slightly lower confidence in ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
